ArticleScientific reports2017

ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.

Haaglim Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.